Bio-Techne (TECH) Income from Continuing Operations (2009 - 2026)

Bio-Techne's (TECH) quarterly Income from Continuing Operations came in at 51047000.0 in Q1 2026, up 125.99% year-on-year from 22588000.0 in Q1 2025, and up 34.3% quarter-over-quarter from 38009000.0 in Q4 2025.

Bio-Techne (TECH) Income from Continuing Operations (2009 - 2026) Analysis & Trends

Bio-Techne's Income from Continuing Operations history runs 18 years deep, the most recent figure standing at 51047000.0 for Q1 2026.

  • On a quarterly basis, Income from Continuing Operations rose 125.99% year-over-year to 51047000.0 in Q1 2026; TTM through Mar 2026 was 22749000.0, a 71.78% decrease from a year earlier, with the FY2025 full-year figure at 13414000.0, down 111.46% from the prior year.
  • Income from Continuing Operations rose to 51047000.0 in Q1 2026 per TECH's latest filing, from 38009000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 89734000.0 in Q3 2022 and bottomed at 104492000.0 in Q2 2025.
  • The 5-year median for Income from Continuing Operations is 49059000.0 (2024), against an average of 37967705.88.
  • Across the five-year window, Income from Continuing Operations jumped 615.95% in 2022 and tumbled 899.35% in 2025, its largest moves.
  • Year by year, Income from Continuing Operations stood at 50005000.0 in 2022, then tumbled by 45.08% to 27465000.0 in 2023, then advanced by 27.03% to 34890000.0 in 2024, then advanced by 8.94% to 38009000.0 in 2025, then jumped by 34.3% to 51047000.0 in 2026.
  • Per Business Quant, the three latest TECH Income from Continuing Operations figures stand at 51047000.0 (Q1 2026), 38009000.0 (Q4 2025), and 38185000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -37.09 Mn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -14.46 Mn
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 227.36 Mn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 1.03 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 727.20 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - -26.94 Mn
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 498.00 Mn
9 Revolution Medicines 37.37 Bn 37.37 Bn - -453.82 Mn
10 Bio-Techne 11.19 Bn 10.98 Bn 208.29 Mn 51.05 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 51.05 Mn
Dec 31, 2025 38.01 Mn
Sep 30, 2025 38.19 Mn
Jun 30, 2025 -104.49 Mn
Mar 31, 2025 22.59 Mn
Dec 31, 2024 34.89 Mn
Sep 30, 2024 33.60 Mn
Jun 30, 2024 -10.46 Mn
Mar 31, 2024 49.06 Mn
Dec 31, 2023 27.47 Mn
Sep 30, 2023 50.99 Mn
Jun 30, 2023 75.48 Mn
Mar 31, 2023 70.22 Mn
Dec 31, 2022 50.01 Mn
Sep 30, 2022 89.73 Mn
Jun 30, 2022 68.98 Mn
Mar 31, 2022 60.14 Mn
Dec 31, 2021 72.06 Mn
Sep 30, 2021 68.98 Mn
Jun 30, 2021 -13.37 Mn